Announcement | Hybio Pharmaceutical Ranked on the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation Capacity List - High-Growth Innovation List

Innovation serves as the primary driving force for Shenzhen's development. 
The "2024 Guangdong - Hong Kong - Macao Greater Bay Area Enterprise Innovation Capacity Ranking List" was officially released at the 5th Session of Shenzhen Enterprise Innovation Promotion Conference and the 2024 Annual Meeting of Shenzhen Industrial Association.

The "Guangdong-Hong Kong-Macao Greater Bay Area (GBA) Enterprise Innovation Capacity List" evaluation and release event, a public welfare initiative aimed at showcasing innovation trends and achievements across the Greater Bay Area, was jointly organized by the Federation of Shenzhen Industries , in collaboration with institutions including the Guangdong Bay Area New Economy Research Institute, Shenzhen Association for Science and Technology , SHENZHEN LEAGUER CO., LTD. , Shenzhen Business News, Shenzhen Innovation and Development Institute, and Guangdong Innovation Competitiveness Economic Research Institute. This annual evaluation highlights enterprises driving technological advancement and sustainable growth within the region.

Hybio Pharmaceutical earned its place on the High-Growth Innovation List through its outstanding R&D capabilities, unwavering quality standards, state-of-the-art production infrastructure, and proven industrialization achievements. The recognition underscores the company’s commitment to advancing pharmaceutical innovation while maintaining rigorous operational excellence. 

The enterprises selected into the "list" have demonstrated outstanding comprehensive strength, including many that have been awarded the titles of national, provincial and municipal manufacturing single-item champion enterprises, as well as national specialized, sophisticated, distinctive and novel "little giant" enterprises. On the whole, the independent innovation capability of these enterprises has been continuously enhanced; they hold prominent positions in their respective industries and drive the integrated development of industrial chains. Most of the individuals on the "List of Outstanding Innovation Figures" are leaders who spearhead the innovative development of enterprises.

High-Growth Innovation List (45 companies).

—  END  —